A repair pathway lost in multiple sclerosis provides a new drug opportunity

Nat Immunol. 2024 Mar;25(3):385-386. doi: 10.1038/s41590-024-01765-5.

Lise Torp Jensen^{1

2}, Kathrine E Attfield², Lars Fugger^{3

4

5}

¹ Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
² Oxford Centre for Neuroinflammation, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
³ Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. lars.fugger@ndcn.ox.ac.uk.
⁴ Oxford Centre for Neuroinflammation, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK. lars.fugger@ndcn.ox.ac.uk.
⁵ MRC Translational Immune Discovery Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK. lars.fugger@ndcn.ox.ac.uk.

No abstract available